Insights from recent episode analysis
Audience Interest
Podcast Focus
Publishing Consistency
Platform Reach
Insights are generated by CastFox AI using publicly available data, episode content, and proprietary models.
Total monthly reach
Estimated from 3 chart positions in 3 markets.
By chart position
- 🇦🇺AU · Nutrition#1115K to 30K
- 🇮🇳IN · Nutrition#1571K to 10K
- 🇮🇪IE · Nutrition#197500 to 3K
- Per-Episode Audience
Est. listeners per new episode within ~30 days
4.5K to 30K🎙 Weekly cadence·44 episodes·Long inactive - Monthly Reach
Unique listeners across all episodes (30 days)
6.5K to 43K🇦🇺70%🇮🇳23%🇮🇪7% - Active Followers
Loyal subscribers who consistently listen
1.9K to 13K
Market Insights
Platform Distribution
Reach across major podcast platforms, updated hourly
Total Followers
—
Total Plays
—
Total Reviews
—
* Data sourced directly from platform APIs and aggregated hourly across all major podcast directories.
On the show
Recent episodes
GLP1 Improving Heart Health
Nov 21, 2024
14m 34s
Rapid evolution of GLP-1: A Comprehensive Update
Nov 16, 2024
22m 20s
Ethics and Accessibility of GLP-1ra Long Term
Nov 11, 2024
13m 43s
What This 2024 Presidential Election Means for GLP-1ra and Big Pharma
Nov 7, 2024
54m 00s
GLP1s - a deeper dive into how they work
Nov 1, 2024
13m 13s
Social Links & Contact
Official channels & resources
Official Website
Login
RSS Feed
Login
| Date | Episode | Description | Length | ||||||
|---|---|---|---|---|---|---|---|---|---|
| 11/21/24 |  GLP1 Improving Heart Health | We discuss the latest news around GLP1 especially as it relates to heart health! | 14m 34s | ||||||
| 11/16/24 |  Rapid evolution of GLP-1: A Comprehensive Update | Discussing the rapid changes happening in the GLP-1 market. An update on everything we know so far. | 22m 20s | ||||||
| 11/11/24 |  Ethics and Accessibility of GLP-1ra Long Term | Discussion on the Ethics of Access, especially for lower income populations looking for weight loss solutions, and the economic feasibility of long-term access for many. | 13m 43s | ||||||
| 11/7/24 |  What This 2024 Presidential Election Means for GLP-1ra and Big Pharma | Today we discuss how the election of Donald J. Trump to the white house as the 47th president of the United States impacts all the stuff we talk about on this podcast: Big Pharma, Weight Loss, GLP1 Medications, Regulations. We also talk about his team: Vivek Ramaswamy, Elon Musk, and others. | 54m 00s | ||||||
| 11/1/24 |  GLP1s - a deeper dive into how they work | Let's really do a deep dive on the mechanisms of GLP1 that we haven't touched on previously. This is going to be a discussion for our long-time followers since we skip past a lot of introductory stuff. | 13m 13s | ||||||
| 10/29/24 |  Current trends in weight loss: What's going on? What's the big picture? | Discussion about all the latest gossip on weight loss from around the country. | 15m 19s | ||||||
| 10/28/24 |  FDA reverses decision to halt compounding of Terzepetide, for now | Discussing the FDAs recent reversal on compounding Terzepitide while they re-evaluate the shortage situation. This and more on today's episode. | 11m 16s | ||||||
| 10/25/24 |  Big Pharma Grilled on GLP1 Pricing; Why are Ozempic and other drugs so expensive? | You don't want to miss this episode! Today, we're looking into GLP1 pricing and how congress is putting BigPharma on the hotseat trying to understand why their drugs cost so much. All that and more on today's episode. | 13m 54s | ||||||
| 10/24/24 |  Novo Nordisk pushes FDA to stop GLP1 compounding citing "complexity' | Today we discuss a major development: Novo Nordisk, the company behind WeGovy and Ozempic, is pushing the FDA to stop compounding pharmacies from manufacturing the compounded medications, citing the complexity of manufacture. Critics say it is just a ploy to secure profits. | 10m 17s | ||||||
| 10/23/24 |  featured sponsor episode: tune-health | Today we're going to do a deep dive into our sponsor and look at the services they offer and how they differ from other services in this space. | 12m 42s | ||||||
Want analysis for the episodes below?Free for Pro Submit a request, we'll have your selected episodes analyzed within an hour. Free, at no cost to you, for Pro users. | |||||||||
| 10/22/24 |  FDA warnings about adverse reactions to GLP1s due to common errors | The discussion is about misdosing compounded medications and how this leads to adverse events. Ultimately, compliance is about being able to stay on a program for the long term benefits of weight loss, while managing the short term side effects. Not following protocol, or inexperienced providers, or errors in self medication can lead to challenges, even hospitalization in some cases (300+ reported cases). So, if you're going to use GLP1s do it safely, and with under the guidance of a professional. Do not go to medspas that promise low prices, only to supply you with badly dosed vials that are incorrectly administered. | 8m 15s | ||||||
| 10/21/24 |  GLP1 and its positive benefit in reducing addictions | Discussion on a fascinating aspect of GLP1s that we are just beginning to understand. Today, we discuss the role of GLP1s in eliminating addiction! | 12m 33s | ||||||
| 10/20/24 |  GLP1 Week in Review (10-20-2024) | Discuss the past week in the news. Talking about GLP1s, Big Pharma, Novartis Pivot Strategy, Unexpected Benefits of GLP1s, the real surprise: GLP1s reduces suicide risk in young adults, and more! | 10m 54s | ||||||
| 10/19/24 |  Common Mistakes People Make on GLP1 Protocols | A discussion on the ten most common mistakes people make when they take these GLP-1 medications. | 11m 21s | ||||||
| 10/18/24 |  What Goes Into Manufacturing GLP-1 | Let's find out what goes into making GLP1s and unravel a little of the mystery behind these medications which seem to be in short supply. | 15m 32s | ||||||
| 10/17/24 |  Effectiveness of Compounded Semaglutide | We're talking Semaglutide folks! A favorite topic amongst our listeners. So, here we go... | 16m 53s | ||||||
| 10/16/24 |  Insurance Coverage for Weight Loss Meds: Challenges & Opportunities | Today it's all about insurance - reviewing some of the challenges & opportunities for expanding coverage in the industry and talking about the state of things. | 5m 15s | ||||||
| 10/15/24 |  Successfully Fighting for Insurance Coverage & Major Insurers Covering GLP1 | Let's discuss some success stories and talk about the importance of thorough documentation, collaboration with healthcare providers, understanding the appeals process, persistence, and utilizing available resources such as patient advocacy groups and copay assistance programs. | 11m 16s | ||||||
| 10/14/24 |  Denied Insurance Coverage? Steps you can take. | We discuss an important topic: What do you do when you are denied coverage for your weight loss medications? Well, we talk about some concrete steps people should look into. | 16m 27s | ||||||
| 10/13/24 |  Weight Loss Drugs & Employer Coverage | Discussion around weight loss drugs and the possibility of employer coverage. Exciting times ahead! Not many employers cover these drugs today, but could that change? Also, what is the impact of these drugs on the federal budget for Medicare? All these and more on this episode. | 7m 45s | ||||||
| 10/12/24 |  Week In Review: GLP-1 in the News (October 12, 2024) | We look at a slew of articles that talk about amazing new things about GLP-1 this week:Glaucoma Reduction PotentialPrescription TrendsSGLP2 Inhibitors vs. GLP1: Kidney Outcomes for DiabeticsHow GLP1s are having impacts in multiple sectorsTirzepatide/GLP1ra in Type II DiabetesConcerns & Issues related to GLP1sAll this and more in this power packed episode! | 10m 06s | ||||||
| 10/12/24 |  Plant Based Diets and GLP1s | Today we're looking into the surprising synergies between GLP1s and plant based diets. | 8m 19s | ||||||
| 10/12/24 |  Neuroplasticity and GLP1s | Discussion around a surprising possibility with GLP1s: Neuroplasticity and its future potential. | 5m 19s | ||||||
| 10/12/24 |  Neuroprotective Effects of GLP1ra and Glaucoma | We're talking about Glaucoma and a surprising side effect of the GLP1 medications. Apparently, they may be neuroprotective. | 8m 23s | ||||||
| 10/12/24 |  Weight Loss & Fertility | Today we're getting into a surprising topic: Apparently, people on GLP1 are suddenly able to get pregnant! Let's get into it. | 11m 04s | ||||||
Showing 25 of 44
Sponsor Intelligence
Sign in to see which brands sponsor this podcast, their ad offers, and promo codes.
Chart Positions
3 placements across 3 markets.
Chart Positions
3 placements across 3 markets.